Compounds > carbapenems
Page last updated: 2024-09-04

carbapenems and 1,4,7-triazacyclononane-n,n',n''-triacetic acid

carbapenems has been researched along with 1,4,7-triazacyclononane-n,n',n''-triacetic acid in 1 studies

Compound Research Comparison

Studies
(carbapenems)		Trials
(carbapenems)		Recent Studies (post-2010)
(carbapenems)		Studies
(1,4,7-triazacyclononane-n,n',n''-triacetic acid)		Trials
(1,4,7-triazacyclononane-n,n',n''-triacetic acid)		Recent Studies (post-2010) (1,4,7-triazacyclononane-n,n',n''-triacetic acid)
7,3551475,2771953161

Protein Interaction Comparison

ProteinTaxonomycarbapenems (IC50)1,4,7-triazacyclononane-n,n',n''-triacetic acid (IC50)
Beta-lactamase Escherichia coli0.1095

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arvidsson, PI; Bester, LA; Chonco, L; Essack, SY; Govender, T; Kruger, HG; Naicker, T; Parboosing, R; Somboro, AM; Tiwari, D1

Other Studies

1 other study(ies) available for carbapenems and 1,4,7-triazacyclononane-n,n',n''-triacetic acid

ArticleYear
NOTA: a potent metallo-β-lactamase inhibitor.
    The Journal of antimicrobial chemotherapy, 2015, Volume: 70, Issue:5

    Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Escherichia coli; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure

2015